The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias
about
Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin systemCardiac aging and heart disease in humansIntersection of cardiovascular disease and kidney disease: atrial fibrillation.Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation.Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacingE-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.Incident atrial fibrillation and risk of death in adults with chronic kidney disease.A genetic contribution to risk for postoperative junctional ectopic tachycardia in children undergoing surgery for congenital heart diseaseHistamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation.Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertensionOxidant stress promotes disease by activating CaMKII.The Role Of Renin Angiotensin System In Atrial Fibrillation.A common angiotensin-converting enzyme polymorphism and preoperative angiotensin-converting enzyme inhibition modify risk of tachyarrhythmias after congenital heart surgery.Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter?Angiotensin-converting enzyme insertion/deletion gene polymorphisms associated with risk of atrial fibrillation: A meta-analysis of 23 case-control studies.Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.Renal function after repeat catheter ablation for long-standing persistent atrial fibrillation : Low CHA2DS2-VASc score and sinus rhythm predict improved renal function.ACE phenotyping in human heart.Role of irbesartan in prevention of post-coronary artery bypass graft atrial fibrillation.Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients.Principles governing heart failure therapy re-examined relative to standard evidence-based medicine-driven guidelines.Angiotensin-(1-7) attenuates atrial tachycardia-induced sympathetic nerve remodeling.Outcomes of ablation of paroxysmal atrial fibrillation in patients on chronic hemodialysis.Relationship between -344T/C polymorphism in the aldosterone synthase gene and atrial fibrillation in patients with essential hypertension.Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?The Renin-Angiotensin-Aldosterone System as a Therapeutic Target in Late Injury Caused by Ischemia-Reperfusion.Evaluation of Atrial Electromechanical Delay to Predict Atrial Fibrillation in Hemodialysis Patients
P2860
Q27026966-984662CA-6375-400A-BE61-3BCC7200A7A5Q33639771-1B7680B7-6947-48F3-A71C-F5B30979D8C8Q34040279-D0A5FA4F-6091-4DD9-B19D-4A966267E48CQ34370565-F29C12C3-DAF8-414F-A1C0-2B0B09204860Q34749676-BBEBF6D6-CA69-4C0C-93F0-29CACCDB0F6CQ34847699-7744BBD5-BF5D-49E1-BEFE-B719C9A82B94Q35070646-919B9B01-5C6B-45B4-8BB7-83656080B80AQ35549364-5E1AE8C8-7FBC-47D3-B456-52A9A2FB9E6FQ35650739-D3DEAB38-E9C2-4EBB-B038-8A3E263A088DQ35805412-51B75F82-459A-4D9C-AAC0-217AD950BB1FQ36193817-4747C2C5-58AC-418E-B18F-6BD6C55D7E53Q36913422-AB88F8D4-DBFE-47C2-8823-DC42908A3D76Q37266655-A033347F-C5F0-4B15-8A8F-7007F7C93515Q37358999-2B6A6C79-F4FB-464A-B4AC-FB378DDF1FD6Q37469038-D22CED2D-75C6-4DCC-86B7-6C9005BB457DQ37730875-8B80CC01-950F-4436-86F0-C9F048AFEE8AQ38198026-A6159951-BB0C-4D8A-9243-86265C2970A3Q38389444-1BEAB2D7-D99F-48DC-B10C-2BD8BB303609Q38714008-0BA7939A-6F2D-4A02-81F4-FF706C6B0A98Q40062971-FA6B2A45-2FBD-45A3-9A67-6DA7FBB656E8Q41235667-E4394613-F003-49FC-A38D-A7296E18D260Q42602840-59FCE167-1E8D-438A-9D21-C22EF7F1D363Q46832076-016CE735-B723-4962-930C-A937D9FCE1D1Q48588516-41BC8DC8-763A-4139-8910-AF3DC2A9B5D1Q50213445-8A118901-19F0-4BE3-BD29-0C14D2B6BAACQ50504872-7C2B6DA3-B9B7-480D-9654-1858C64F0663Q54353741-22B2F0ED-8CC6-4BAA-B8BE-589E7639242AQ54720771-1E4C6933-6DEA-411C-9E64-1E074BFB11BCQ55035093-598207C6-01C1-4FD0-BBBC-8CC9658DF18FQ57823567-EBE7790A-9CBD-411A-BF90-CBCF681505CA
P2860
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias
@en
The renin-angiotensin-aldosterone system
@nl
type
label
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias
@en
The renin-angiotensin-aldosterone system
@nl
prefLabel
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias
@en
The renin-angiotensin-aldosterone system
@nl
P2860
P1433
P1476
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias
@en
P2093
Samuel C Dudley
Shahriar Iravanian
P2860
P356
10.1016/J.HRTHM.2008.02.025
P433
P577
2008-03-04T00:00:00Z